An innovative point-of-care platform, featuring its first test for the measurement of high-sensitivity cardiac troponin I from a single drop of blood

Background: Standardised tacrolimus trough-level targets limit individualisation of immunosuppressive therapy in kidney transplant recipients. Torque teno virus

In the relentless pursuit of healthcare efficiency and better patient care, one truth is becoming increasingly clear: diagnostics are not just clinical tools—they are economic engines.

For patients at risk of sepsis, time matters. Faster diagnostic information can help healthcare teams identify the cause of infection sooner, supporting earlier better-informed care decisions.

In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

For patients at risk of sepsis, time matters. Faster diagnostic information can help healthcare teams identify the cause of infection sooner, supporting earlier better-informed care decisions.

Ebola disease (EBOD), a devastating hemorrhagic disease that is often fatal, has been plaguing Africa since its initial discovery in 1976.

We conducted a national, multicenter retrospective study of ICU patients with pneumonia admitted to Veterans Health Administration hospitals.

Learn how bioMérieux is supporting Ebola outbreak response efforts through rapid diagnostic solutions, expanded testing capacity, and public health partnerships.

Register now!

Biomarker-guided immunosuppression following kidney transplantation successfully tested

Wed, Jun 17, 2026 4:00 PM - 5:00 PM CEST

Last week, the Global Point Prevalence Survey community gathered for its annual meeting, held in collaboration with bioMérieux at the opening of the ESCMID Global 2026 congress in Munich. With 240 par...

bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

Together we help make the world a healthier place

A coalition of more than 20 international partners announced the Global One Health Diagnostics Access Compact (GO-Dx) during the G7 One Health Summit in Lyon, France. This new initiative serves as a catalyst for international leaders across different sectors to advance progress toward expanding diagnostics access, enabling early detection and better surveillance, and improving response against existing and emerging threats across human, animal, and environmental health. By aligning efforts, this group aims to strengthen global preparedness through science based One Health solutions.

In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.